In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flebocortid Drug Master File in Korea (Flebocortid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flebocortid. The MFDS reviews the Flebocortid KDMF as part of the drug registration process and uses the information provided in the Flebocortid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flebocortid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flebocortid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flebocortid suppliers with KDMF on PharmaCompass.